J Global Clinical Engineering Vol.7 Issue 1, 2025 2 Editor’s Corner Artificial Intelligence in Clinical and Biomedical Engineering: Opportunities and Challenges Never has technology brought so much confusion. For some, AI is the savior of humanity; for others, it is an agent of destruction. The overwhelming fact is that AI is here to stay. But is AI good or bad, and what is its role in biomedical and clinical engineering? To answer this, we need to understand AI’s capabilities, limitations, and evolution while also considering how we should partici- pate in its development and responsible use. AI, in a general sense, is an information system capable of replicating functions traditionally associated with the human brain. From the invention of writing to digital calculators and personal computers, AI has evolved into today’s large language models—deep artificial neural networks capable of processing vast amounts of data and mimicking human language. Yet, AI remains a probabilistic computational engine that generates responses based on its training data. If a system lacks the correct data, it may still generate an answer—a phenomenon known as hallucination. This raises concerns, particularly in decision support, where AI should either provide evidence-based guidance or indicate the need for additional information. AI’s Potential in Clinical and Biomedical Engineering While AI is still emerging in clinical engineering, several areas present significant opportunities: • Decision Support Systems: AI can assist in procure- ment, maintenance scheduling, and calibration, improving efficiency and decision-making. • Predictive Maintenance: AI-driven analytics can anticipate device failures, minimizing downtime and enhancing reliability. • Inventory Management: AI can optimize medical device supply chains, ensuring timely access to critical equipment. • Post-Market Surveillance: AI has the potential to enhance monitoring of medical device performance and early detection of malfunctions. • Cybersecurity Measures: As medical devices become more connected, AI can detect and prevent cyber- security threats. Challenges and Considerations Despite its promise, AI adoption in clinical engineering faces several challenges: • Data Privacy and Security: Compliance with HIPAA and GDPR is essential to protect patient information. • Algorithmic Bias: AI models must be trained on di- verse datasets to avoid biases that could negatively impact healthcare outcomes. For instance, an AI sys- tem trained exclusively on maintenance data from a single manufacturer may yield recommendations that are inapplicable to other brands. Moreover, biases in patient datasets can lead to disparities in healthcare access and outcomes, making it crucial for clinical engineers to contribute to dataset diversification and validation. • Environmental and Operational Context: AI models developed in high-resource settings may not perform effectively in low- and middle-income (LMI) envi- ronments, where infrastructure reliability varies. AI must be trained with data reflective of different operational contexts, including settings with limited electricity, refrigeration, and water supply. Clinical engineers play a vital role in ensuring AI models consider these variables to maintain relevance across diverse healthcare environments. • Explainability and Transparency: AI systems should include interpretability layers so that engineers and healthcare providers understand the decision-mak- ing process. http://www.globalce.org http://www.globalce.org 3 J Global Clinical Engineering Vol.7 Issue 1, 2025 • Workforce Adaptation: Clinical engineers must seek and receive AI training, including ethics and data governance, to oversee AI integration safely and effectively. Future Directions and Recommendations To leverage AI’s potential in clinical and biomedical engineering, the following steps should be considered: 1. Develop AI-based decision support systems for main- tenance, procurement, and calibration. 2. Implement cybersecurity frameworks to safeguard AI-driven medical device networks. 3. Diversify AI training datasets by including various pa- tient populations and multiple medical device brands to mitigate algorithmic bias. 4. Ensure AI transparency by integrating explainability features to enhance trust and usability. 5. Explore AI applications in predictive diagnosis, early failure detection, and resource optimization. 6. Establish AI training programs for clinical engineers to promote ethical and effective implementation. 7. Develop domain-specific large language models (LLMs) tailored to clinical and biomedical engineering, ensuring AI recommendations are contextually appropriate. 8. Publish about best practices, and application of AI into Clinical Engineering practices. You may help many to avoid missteps shared in your publication. Conclusion AI presents a transformative opportunity for clinical and biomedical engineering, with the potential to enhance safety, efficiency, and decision-making. However, respon- sible AI adoption requires addressing data privacy, algo- rithmic bias, and transparency. By proactively engaging in AI development and governance, clinical engineers can play a pivotal role in shaping the future of healthcare technology management. We must embrace our role as toolmakers, not just users, to shape AI into a force for good. Only through intentional development can we create ethical, intelligent systems that enhance efficiency, reduce risk, and improve the quality of life for both patients and technology users. AI is still in its infancy, and we must act as responsible teachers and stewards, guiding its evolution toward cooperation and progress. The alternative is too dangerous—without ethical oversight, unscrupulous corporations, negligent engineers, or uninformed users could steer AI toward harm rather than progress. Ricardo Silva PhD, MBA, CCE Global expert in Healthcare Digital Transformation and Innovation Copyright © 2025. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY): Creative Commons - Attribution 4.0 International - CC BY 4.0. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. http://www.globalce.org http://www.globalce.org